-
- 抗原 See all MORF4L1 抗体
- MORF4L1 (Mortality Factor 4 Like 1 (MORF4L1))
-
抗原表位
- AA 328-360
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This MORF4L1 antibody is un-conjugated
-
应用范围
- Western Blotting (WB)
- 预测反应
- M
- 纯化方法
- This antibody is purified through a protein A column, followed by peptide affinity purification.
- 免疫原
- This MORF4L1 antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 328-360 amino acids from human MORF4L1.
- 克隆位点
- RB54237
- 亚型
- Ig Fraction
- Top Product
- Discover our top product MORF4L1 Primary Antibody
-
anti-Mortality Factor 4 Like 1 (MORF4L1) (N-Term) antibody
Verified MORF4L1 适用: 人, 小鼠, 大鼠, Pig WB, ELISA, IHC 宿主: 山羊 Polyclonal unconjugated
anti-Mortality Factor 4 Like 1 (MORF4L1) (Middle Region) antibodyMORF4L1 适用: 人, 小鼠, 大鼠, Cow, 犬, 马, 兔, 斑马鱼, 豚鼠 WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-Mortality Factor 4 Like 1 (MORF4L1) antibodyMORF4L1 适用: 人, 小鼠, 大鼠 WB, ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-Mortality Factor 4 Like 1 (MORF4L1) (AA 1-100) antibodyMORF4L1 适用: 人 WB, ELISA 宿主: 小鼠 Monoclonal 6B6 unconjugated
anti-Mortality Factor 4 Like 1 (MORF4L1) (N-Term) antibodyMORF4L1 适用: 人, 小鼠, 大鼠 WB, ELISA, IF, ICC 宿主: 兔 Polyclonal unconjugated
anti-Mortality Factor 4 Like 1 (MORF4L1) (AA 251-295) antibodyMORF4L1 适用: 人, 小鼠, 大鼠, Cow, 犬, 马, 兔, 斑马鱼, 豚鼠, Pig, 猴, Bat, 小鸡 WB, IHC, IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-Mortality Factor 4 Like 1 (MORF4L1) (Middle Region) antibodyMORF4L1 适用: 人, 小鼠, 大鼠, 犬, 斑马鱼 WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-Mortality Factor 4 Like 1 (MORF4L1) (N-Term) antibodyMORF4L1 适用: 人, 小鼠, 大鼠, Cow, 犬, 马, 兔, 斑马鱼, 豚鼠 WB 宿主: 兔 Polyclonal unconjugated
anti-Mortality Factor 4 Like 1 (MORF4L1) (AA 1-100) antibodyMORF4L1 适用: 人 ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-Mortality Factor 4 Like 1 (MORF4L1) (AA 1-100) antibodyMORF4L1 适用: 人 WB, ELISA, IHC 宿主: 兔 Polyclonal unconjugated
-
- 应用备注
- WB: 1:2000
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- 4 °C,-20 °C
- 有效期
- 6 months
-
- 抗原
- MORF4L1 (Mortality Factor 4 Like 1 (MORF4L1))
- 别名
- MORF4L1 (MORF4L1 产品)
- 别名
- Eaf3 antibody, HsT17725 antibody, MEAF3 antibody, MORFRG15 antibody, MRG15 antibody, S863-6 antibody, TEG-189 antibody, Tex189 antibody, mKIAA4002 antibody, MORF4L2 antibody, CG6363 antibody, DmMRG15 antibody, Dmel\\CG6363 antibody, Dmrg15 antibody, Mrg15 antibody, dMRG15 antibody, dMrg15 antibody, l(3)j6A3 antibody, zgc:92289 antibody, mortality factor 4 like 1 antibody, MORF-related gene 15 antibody, MRG15 antibody, mortality factor 4 like 1 S homeolog antibody, MORF4L1 antibody, Morf4l1 antibody, MRG15 antibody, CpipJ_CPIJ013367 antibody, morf4l1.S antibody, morf4l1 antibody
- 背景
- Component of the NuA4 histone acetyltransferase (HAT) complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histones H4 and H2A. This modification may both alter nucleosome - DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription. This complex may be required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis, and DNA repair. The NuA4 complex ATPase and helicase activities seem to be, at least in part, contributed by the association of RUVBL1 and RUVBL2 with EP400. NuA4 may also play a direct role in DNA repair when directly recruited to sites of DNA damage. Also component of the mSin3A complex which acts to repress transcription by deacetylation of nucleosomal histones. Required for homologous recombination repair (HRR) and resistance to mitomycin C (MMC). Involved in the localization of PALB2, BRCA2 and RAD51, but not BRCA1, to DNA-damage foci.
- 分子量
- 41474
- UniProt
- Q9UBU8
- 途径
- Chromatin Binding
-
You are here:
